Pharmacological Treatment of Comorbid Alcohol and Marijuana Withdrawal and Dependence
Status:
Completed
Trial end date:
2016-12-19
Target enrollment:
Participant gender:
Summary
The primary aim of the supplemental study is to provide POC testing of aprepitant as a
treatment for comorbid alcohol and cannabis dependence. The data analysis plan specified in
the parent grant will likewise be applied to the supplemental project to test for effects of
aprepitant vs placebo on measures of alcohol and cannabis use and protracted withdrawal. The
primary hypothesis is that subjects treated with aprepitant will have significantly less
alcohol and marijuana use than subjects treated with placebo.